Bayer A.G. makers of a heart surgery drug Trasylol recently halted the sale of the drug because of increased deaths and LegalView immediately updated its site with information for users.
United States of America (Press Release) November 8, 2007 --
Denver, CO - November 6, 2007
Makers of the heart surgery drug, Trasylol, faced pressures from regulators around the world recently to halt sales of the controversial drug when a Canadian study indicated that the drug may actually contribute to increased death rates in users. Trasylol is used to reduce the risks of excessive bleeding to those receiving heart surgery. Bayer A.G.'s drug, Trasylol, also known as asprotinin, was also linked in a 2006 study in the New England Journal of Medicine as having increased risks for stroke, heart attack and kidney failure in patients. LegalView, your source for everything legal, immediately updated its site to host a detailed Trasylol information portal, which includes continually updated information as the issue progresses. LegalView is dedicated to users' finding the most appropriate and useful Trasylol information, which is why the site also includes information on finding a Trasylol attorney based on location.
According to news reports, the Food and Drug Administration initially requested the drug begin a phased withdrawal believing the benefits of a complete and immediate recall did not outweigh the risks posed to heart surgery patients having to do without medication to lessen blood loss. The makers of the drug have said that of the nearly 200,000 users of the drug in 2006, over half were users in the United States. LegalView's information portal provides links to a Trasylol law firm, for those who may have taken the drug and are potentially at risk. LegalView's Trasylol information portal is easy-to-use and highlights the latest details on the unfolding event.
In addition to details regarding the Trasylol recall, LegalView provides regularly updated information on the latest legal issues including information regarding a brain injury attorney. LegalView can also connect victims of mesothelioma cancer with a mesothelioma law firm and those needing to reach nephrogenic systemic fibrosis lawyers, who can help victims access current legal information and jury verdicts. LegalView's site has a hefty amount of information pertaining to the most relevant and significant issues facing Americans today. By accessing the site, users will discover blogs, video libraries, articles and government links for several of these issues.
About LegalView:
LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation formed by the nation's most distinguished law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's well-regarded sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.
Makers of the heart surgery drug, Trasylol, faced pressures from regulators around the world recently to halt sales of the controversial drug when a Canadian study indicated that the drug may actually contribute to increased death rates in users. Trasylol is used to reduce the risks of excessive bleeding to those receiving heart surgery. Bayer A.G.'s drug, Trasylol, also known as asprotinin, was also linked in a 2006 study in the New England Journal of Medicine as having increased risks for stroke, heart attack and kidney failure in patients. LegalView, your source for everything legal, immediately updated its site to host a detailed Trasylol information portal, which includes continually updated information as the issue progresses. LegalView is dedicated to users' finding the most appropriate and useful Trasylol information, which is why the site also includes information on finding a Trasylol attorney based on location.
According to news reports, the Food and Drug Administration initially requested the drug begin a phased withdrawal believing the benefits of a complete and immediate recall did not outweigh the risks posed to heart surgery patients having to do without medication to lessen blood loss. The makers of the drug have said that of the nearly 200,000 users of the drug in 2006, over half were users in the United States. LegalView's information portal provides links to a Trasylol law firm, for those who may have taken the drug and are potentially at risk. LegalView's Trasylol information portal is easy-to-use and highlights the latest details on the unfolding event.
In addition to details regarding the Trasylol recall, LegalView provides regularly updated information on the latest legal issues including information regarding a brain injury attorney. LegalView can also connect victims of mesothelioma cancer with a mesothelioma law firm and those needing to reach nephrogenic systemic fibrosis lawyers, who can help victims access current legal information and jury verdicts. LegalView's site has a hefty amount of information pertaining to the most relevant and significant issues facing Americans today. By accessing the site, users will discover blogs, video libraries, articles and government links for several of these issues.
About LegalView:
LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation formed by the nation's most distinguished law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's well-regarded sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.
Email
Print
SPAM
LEAVE A COMMENT
